Endocardial fibroelastosis

From WikiMD's Food, Medicine & Wellnesspedia

Endocardial Fibroelastosis is a rare heart condition, typically affecting children and infants. It is characterized by a thickening of the inner lining of the heart chambers due to an increase in the amount of supporting connective tissue and elastic fibers. This condition can lead to heart failure and other complications.

Causes[edit | edit source]

The exact cause of Endocardial Fibroelastosis is unknown. However, it is believed to be associated with a viral infection, particularly the Coxsackie B virus. Other potential causes include genetic factors and certain medications.

Symptoms[edit | edit source]

Symptoms of Endocardial Fibroelastosis can vary greatly depending on the severity of the condition. Common symptoms include:

  • Shortness of breath
  • Fatigue
  • Rapid heartbeat
  • Swelling in the legs, ankles, and feet

Diagnosis[edit | edit source]

Diagnosis of Endocardial Fibroelastosis is typically made through a combination of physical examination, medical history, and diagnostic tests. These tests may include an Echocardiogram, Electrocardiogram, and Cardiac MRI.

Treatment[edit | edit source]

Treatment for Endocardial Fibroelastosis is aimed at managing the symptoms and preventing further damage to the heart. This may include medications to help the heart pump more effectively, reduce fluid buildup, and slow the heart rate. In severe cases, a Heart transplant may be necessary.

Prognosis[edit | edit source]

The prognosis for individuals with Endocardial Fibroelastosis can vary greatly depending on the severity of the condition and the individual's overall health. With proper treatment and management, many individuals can lead a normal life.

See also[edit | edit source]

Endocardial fibroelastosis Resources
Doctor showing form.jpg
Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD